Indication: It is suitable for patients over 12 years old, used to treat mild and moderate infections caused by the following sensitive bacteria: 1. Acute exacerbation of chronic bronchitis: caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. 2. Acute bronchitis: caused by Moraxella catarrhalis and Streptococcus pneumoniae. 3. Community-acquired pneumonia: caused by Legionella pneumophila, Mycoplasma pneumoniae, and Streptococcus pneumoniae. 4. Pharyngitis and tonsillitis: caused by Streptococcus pyogenes. 5. Simple skin and soft tissue infections: caused by Staphylococcus aureus (methicillin-sensitive strains) and Streptococcus pyogenes. Note: Penicillin is a commonly used drug for the treatment and prevention of streptococcal infections (including the prevention of rheumatic fever). Generally speaking, erythromycin is effective in the treatment of nasopharyngitis caused by Streptococcus pyogenes and can eradicate it; its efficacy in preventing rheumatic fever is still unknown.

Indication: It is suitable for patients over 12 years old, used to treat mild and moderate infections caused by the following sensitive bacteria: 1. Acute exacerbation of chronic bronchitis: caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. 2. Acute bronchitis: caused by Moraxella catarrhalis and Streptococcus pneumoniae. 3. Community-acquired pneumonia: caused by Legionella pneumophila, Mycoplasma pneumoniae, and Streptococcus pneumoniae. 4. Pharyngitis and tonsillitis: caused by Streptococcus pyogenes. 5. Simple skin and soft tissue infections: caused by Staphylococcus aureus (methicillin-sensitive strains) and Streptococcus pyogenes. Note: Penicillin is a commonly used drug for the treatment and prevention of streptococcal infections (including the prevention of rheumatic fever). Generally speaking, erythromycin is effective in the treatment of nasopharyngitis caused by Streptococcus pyogenes and can eradicate it; its efficacy in preventing rheumatic fever is still unknown.

Indication: For the following mild and moderate infections caused by sensitive bacteria. Upper respiratory tract infection Streptococcus pyogenes pharyngitis/tonsillitis. Note: Intramuscular penicillin should usually be selected for the treatment and prevention of streptococcal infections (including the prevention of rheumatic fever). Although cefprozil can generally effectively eliminate Streptococcus pyogenes in the nasopharynx, there is currently no reference data on the use of cefprozil in the prevention of secondary rheumatic fever. Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). Acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). Lower respiratory tract infection Acute bronchitis secondary to bacterial infection and acute exacerbation of chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). Skin and skin tissue infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes are uncomplicated, but abscesses usually require surgical drainage. Bacterial culture and susceptibility testing should be performed to determine the susceptibility of the pathogen to cefprozil when appropriate.

Indication: Used for the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infections ⑴ Streptococcus pyogenes pharyngitis/tonsillitis. Note: Intramuscular penicillin should usually be used to treat and prevent streptococcal infections (including prevention of rheumatic fever). Although cefuroxime can generally effectively eliminate Streptococcus pyogenes in the nasopharynx, there is currently no reference data on the use of cefuroxime to prevent secondary rheumatic fever. ⑵ Otitis media and acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including B-lactamase-producing strains) and Moraxella catarrhalis (including B-lactamase-producing strains). 2. Lower respiratory tract infections caused by Streptococcus pneumoniae, Haemophilus influenzae

Indication: For mild and moderate infections caused by sensitive bacteria. Upper respiratory tract infection, purulent streptococcal pharyngitis/tonsillitis. Note: Intramuscular penicillin should be selected for the treatment and prevention of streptococcal infections (including the prevention of rheumatic fever). Although cefprozil is generally effective in clearing purulent streptococci in the nasopharynx, there is currently no data available for the use of cefprozil in the prevention of secondary rheumatic fever. Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Lower respiratory tract infection, secondary bacterial infection of acute bronchitis and acute exacerbation of chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Skin and skin tissue infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes are uncomplicated, but abscesses usually require surgical drainage.

Indication: It is used for the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection. 2. Lower respiratory tract infection. 3. Skin and skin soft tissue infection.

Indication: It is used for the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection. 2. Lower respiratory tract infection. 3. Skin and skin soft tissue infection.

Indication: For the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection, Streptococcus pyogenes pharyngitis/tonsillitis. Note: Intramuscular penicillin should usually be used to treat and prevent streptococcal infections (including prevention of rheumatic fever). Although cefprozil can generally effectively eliminate Streptococcus pyogenes in the nasopharynx, there is currently no reference data on the use of cefprozil to prevent secondary rheumatic fever. Otitis media and acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). 2. Lower respiratory tract infection, secondary bacterial infection of acute bronchitis and acute exacerbation of chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). 3. Uncomplicated skin and skin soft tissue infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes, but abscesses usually require surgical drainage. Bacterial culture and drug sensitivity testing should be performed when appropriate to determine the sensitivity of the pathogen to cefprozil.